We have collected information about Biodelivery Sciences Onsolis for you. Follow the links to find out details on Biodelivery Sciences Onsolis.
http://ir.bdsi.com/news-releases/news-release-details/biodelivery-sciences-reacquires-onsolisr-collegium
Dec 14, 2017 · RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced that it has received the required 90-day notice from Collegium Pharmaceutical, Inc. regarding termination of the license and development agreement for ONSOLIS ® (fentanyl buccal soluble film) between BDSI and Collegium. BDSI and Collegium entered …
BioDelivery Sciences (BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive ...
https://www.marketwatch.com/press-release/biodelivery-sciences-reacquires-onsolisr-from-collegium-pharmaceutical-2017-12-14
Dec 14, 2017 · About BioDelivery Sciences International. BioDelivery Sciences International, Inc. BDSI, -2.05% is a specialty pharmaceutical company with a focus in …
http://ir.bdsi.com/news-releases/news-release-details/biodelivery-sciences-acquires-north-american-marketing
Jan 27, 2015 · Transaction provides BDSI the opportunity to seek a new partner for ONSOLIS in the U.S., Canada and Mexico RALEIGH, N.C., Jan. 27, 2015 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that it has entered into an assignment and revenue sharing agreement with Meda AB (Meda) under which Meda will transfer the marketing …
https://www.prnewswire.com/news-releases/biodelivery-sciences-acquires-north-american-marketing-authorizations-for-onsolis-from-meda-300025894.html
BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda Transaction provides BDSI the opportunity to seek a new partner for ONSOLIS in …
https://bdsi.com/BEMA-Technology/
BEMA films are designed to: Adhere to oral mucosa in less than 5 seconds; Optimize delivery across the oral mucosa; Completely dissolve; Following the successful development and approval of the first product utilizing the BEMA technology, we began to apply the same technology to improve the delivery of other therapies, such as buprenorphine and buprenorphine/naloxone.
Searching for Biodelivery Sciences Onsolis?
You can just click the links above. The data is collected for you.
